Novexel Starts Phase II Clinical Trial With NXL103 In Adults With Acute Bacterial Skin And Skin Structure Infections (ABSSSI)

Links shared publicly online about this topic.

  • 1,620
    total visits

Novexel Starts Phase II Clinical Trial With NXL103 In Adults With Acute Bacterial Skin And Skin Structure Infections (ABSSSI)

medicalnewstoday.com —

Novexel, a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance, announces th

View full resource at medicalnewstoday.com

Tags: Skin, Infection, Pharma, Clinical Trial, Antibiotic

  • Share

Most Recently Shared on November 7, 2009 at 1:30 pm By:

mnt_clinical MNT Clinical Trials

Novexel Starts Phase II Clinical Trial With NXL103 In Adults With Acute Bacterial Skin And Skin Structure Infec.. http://bit.ly/2woxZM

3 years ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Dermatology News MNT Dermatology News

Advertisement